US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class II · Moderate risk Terminated

Pt-141

Reason Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.

North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding D-0780-2022
Class II · Moderate risk Terminated

Melanotan II 1 mg/mL

Reason Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.

North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding D-0779-2022
Class II · Moderate risk Terminated

LL-37 2 mg/mL

Reason Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.

North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding D-0778-2022
Class II · Moderate risk Terminated

Ipamorelin Acetate/Sermorelin Acetate

Reason Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.

North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding D-0777-2022
Class II · Moderate risk Terminated

BPC-157 2 mg/mL

Reason Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.

North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding D-0776-2022
Class II · Moderate risk Terminated

Ara-290

Reason Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.

North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding D-0775-2022
Class III · Low risk Terminated

Cyanocobalamin Injection

Reason Subpotent Drug: Out of Specification results for Assay

Aurobindo Pharma USA Inc. NDC 55150-364-01 D-0766-2022
Class II · Moderate risk Terminated

BEAK & SKIFF SANITIZER Alcohol Antiseptic 80%

Reason CGMP Deviations: FDA analysis found product to contain acetaldehyde above specification limits.

Beak & Skiff Cider Mill, Inc. N/A
Class II · Moderate risk Terminated

Hydroxocobalamin B12

Reason CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0080-30 D-0826-2022
Class II · Moderate risk Terminated

Ultratest

Reason CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0058-10 D-0825-2022
Class II · Moderate risk Terminated

Testosterone Cypionate 200 mg/mL

Reason CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0055-10 D-0824-2022
Class II · Moderate risk Terminated

Testosterone Cypionate 200 mg/mL

Reason CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0054-10 D-0823-2022
Class II · Moderate risk Terminated

Phenylephrine 1 mg/mL

Reason CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0021-05 D-0822-2022
Class II · Moderate risk Terminated

Formula F2

Reason CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0002-10 D-0821-2022
Class II · Moderate risk Terminated

T-50

Reason CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0022-10 D-0820-2022
Class II · Moderate risk Terminated

Pge-3

Reason CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0030-10 D-0819-2022
Class II · Moderate risk Terminated

Pge-2

Reason CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0029-10 D-0818-2022
Class II · Moderate risk Terminated

Pge-1

Reason CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0028-10 D-0817-2022
Class II · Moderate risk Terminated

FA, Papaverine 20 mg/mL . Phentolamine 2 mg/mL . Alprostadil 20…

Reason CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0006-10 D-0816-2022
Class II · Moderate risk Terminated

Bimix-3

Reason CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0027-10 D-0815-2022
Class II · Moderate risk Terminated

Re-2

Reason CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0016-10 D-0814-2022
Class II · Moderate risk Terminated

Re-1

Reason CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0015-10 D-0813-2022